Title: Clinical Trials of Bone Marrow Cell Proliferation
Author: Mao Renhuan
Date: 1989-08-13
Edition: 7

Bone marrow cell proliferation involves the ex vivo culture of bone marrow cells, including various precursor cells of white blood cells and red blood cells present in the bone marrow, as well as embryonic stem cells and all white blood cell precursors. This technology equally promotes the proliferation of all cells, thereby increasing the amount of bone marrow available for transplantation. In clinical trials, this technology requires only a few grams of bone marrow for transplantation, instead of the usual 0.5 grams to 1 liter. If successful, bone marrow cell proliferation can improve the effectiveness of autologous bone marrow transplantation and reduce the inherent rejection reaction of the transplanted organ from one person to another. Potential applications include establishing bone marrow banks for patients undergoing chemotherapy and radiation therapy, as these treatments can kill bone marrow cells. It can also be used for individuals exposed to harmful substances, such as those in contact with dangerous chemicals. Foreign bone marrow technology companies are very active in this area and are currently conducting human clinical trials using this technology.


<hr /> 

Original: 


### 骨髓细胞繁殖临床试验
毛仁焕
1989-08-13
第7版(国际专页)
专栏：

    骨髓细胞繁殖临床试验
    骨髓细胞繁殖涉及离体骨髓细胞培养，其中包括在骨髓中存在的许多白细胞和红细胞的前体细胞，以及胚细胞和一切白细胞前体。该技术对所有细胞的增殖相等，使可用于移植的骨髓量扩增。在临床试验中，采用该技术，只需用几克骨髓就能完成移植，而不是通常的0.5克到1升的骨髓。如果获得成功，骨髓细胞繁殖可使自体同源骨髓移植效果更佳，而且减轻骨髓从一个人移植另一个人所固有的对移植器官的排斥反应。它可开发的应用包括：作经受化学治疗和辐射治疗病人的骨髓库。因这两种疗法会杀死骨髓细胞；可用于接触有害物质的人，如接触危险化学品的人。国外骨髓技术公司在这方面十分活跃，现在正采用该项技术进行人的临床试验。
        （毛仁焕编译）
